TY Howton
Förmögenhet: 846 921 $ per 2026-07-31
Förmögenhet: 846 921 $ per 2026-07-31
David Tyronne Howton is Director at Biogene Therapeutics, Inc. since 2026.
Mr. Howton is Chief Operating Officer & Secretary at Solid Biosciences, Inc. since 2023.
Former roles include Director at Make-A-Wish Foundation of Massachusetts, Chief Healthcare Compliance Officer at Genentech, Inc., Secretary, Chief Legal Officer & Senior VP at Vertex Pharmaceuticals, Inc. in 2012, Secretary, Senior Vice President & General Counsel at Sarepta Therapeutics, Inc. from 2013 to 2020, and Chief Operating Officer & General Counsel at AavantiBio, Inc. from 2021 to 2022.
Education includes undergraduate studies at Yale University and graduate studies at Northwestern University School of Law.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
SOLID BIOSCIENCES INC. 0,11 % | 2026-03-31 | 105 077 ( 0,11 % ) | 846 921 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| SOLID BIOSCIENCES INC. | Verksamhetschef | 2023-09-01 |
| Företag | Position | Slut |
|---|---|---|
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Verksamhetschef | 2022-12-01 |
| SAREPTA THERAPEUTICS, INC. | Generell Rådgivare | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Generell Rådgivare | 2012-06-12 |
Make-A-Wish Foundation of Massachusetts | Direktör/Styrelseledamot | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Make-A-Wish Foundation of Massachusetts | |
Northwestern University School of Law
Northwestern University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån